Older Age Does Not Increase Risk of Hemorrhagic Complications after Intravenous and/or Intra-Arterial Thrombolysis for Acute Stroke

Journal of Stroke and Cerebrovascular Diseases

Volumn 17, Issue 5, 2008, Pages 266-272

  Pundik, Svetlna ^a,b   McWilliams Dunnigan, Laurie ^a   Blackham, Kristine L ^a   Kirchner, H L ^c   Sundararajan, Sophia ^a   Sunshine, Jeffrey L ^a   Tarr, Robert W ^a   Selman, Warren R ^a   Landis, Dennis M ^d   Suarez, Jose I ^d  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

acute; elderly; hemorrhage; intracranial; Stroke; therapeutic thrombolysis

Indexed keywords

ALTEPLASE; GLUCOSE; UROKINASE;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FIBRINOLYTIC THERAPY; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HUMAN; HYPERGLYCEMIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RECANALIZATION; RISK ASSESSMENT;

ACUTE DISEASE; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; DRUG ADMINISTRATION ROUTES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INTRACRANIAL HEMORRHAGES; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; YOUNG ADULT;

EID: 49849087927     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2008.03.003     Document Type: Article

References (32)

1. Rosamond W., Flegal K., Friday G., et al. Heart disease and stroke statistics-2007 update: A report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation 115 (2007) e69-e171
2. Kammersgaard L.P., Jorgensen H.S., Reith J., et al. Short- and long-term prognosis for very old stroke patients: The Copenhagen stroke study. Age Ageing 33 (2004) 149-154
3. Kelly-Hayes M., Beiser A., Kase C.S., et al. The influence of gender and age on disability following ischemic stroke: The Framingham study. J Stroke Cerebrovasc Dis 12 (2003) 119-126
4. Kidwell C.S., Saver J.L., Carneado J., et al. Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke 33 (2002) 717-724
5. Larrue V., von Kummer R., del Zoppo G., et al. Hemorrhagic transformation in acute ischemic stroke: Potential contributing factors in the European cooperative acute stroke study. Stroke 28 (1997) 957-960
6. Tanne D., Turgeman D., and Adler Y. Management of acute ischemic stroke in the elderly: Tolerability of thrombolytics. Drugs 61 (2001) 1439-1453
7. Engelter S.T., Reichhart M., Sekoranja L., et al. Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis. Neurology 65 (2005) 1795-1798
8. Simon J.E., Sandler D.L., Pexman J.H., et al. Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischemic stroke? The Calgary experience. Age Ageing 33 (2004) 143-149
9. Sylaja P.N., Cote R., Buchan A.M., et al. Thrombolysis in patients older than 80 years with acute ischemic stroke: Canadian alteplase for stroke effectiveness study. J Neurol Neurosurg Psychiatry 77 (2006) 826-829
10. Kim D., Ford G.A., Kidwell C.S., et al. Intra-arterial thrombolysis for acute stroke in patients 80 and older: A comparison of results in patients younger than 80 years. AJNR Am J Neuroradiol 28 (2007) 159-163
11. Furlan A., Higashida R., Wechsler L., et al. Intra-arterial prourokinase for acute ischemic stroke: The PROACT II study; a randomized controlled trial, Prolyse in acute cerebral thromboembolism. JAMA 282 (1999) 2003-2011
12. Suarez J.I., Sunshine J.L., Tarr R., et al. Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. Stroke 30 (1999) 2094-2100
13. Suarez J.I., Zaidat O.O., Sunshine J.L., et al. Endovascular administration after intravenous infusion of thrombolytic agents for the treatment of patients with acute ischemic strokes. Neurosurgery 50 (2002) 251-259
14. Zaidat O.O., Suarez J.I., Santillan C., et al. Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion. Stroke 33 (2002) 1821-1826
15. Trouillas P., and von Kummer R. Classification and pathogenesis of cerebral hemorrhages after thrombolysis in ischemic stroke. Stroke 37 (2006) 556-561
16. Berrouschot J., Rother J., Glahn J., et al. Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (> or =80 years) stroke patients. Stroke 36 (2005) 2421-2425
17. Mouradian M.S., Senthilselvan A., Jickling G., et al. Intravenous rt-PA for acute stroke: Comparing its effectiveness in younger and older patients. J Neurol Neurosurg Psychiatry 76 (2005) 1234-1237
18. Tanne D., Gorman M.J., Bates V.E., et al. Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older: The tPA stroke survey experience. Stroke 31 (2000) 370-375
19. Tanne D., Kasner S.E., Demchuk A.M., et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: The multicenter rt-PA stroke survey. Circulation 105 (2002) 1679-1685
20. van Oostenbrugge R.J., Hupperts R.M., and Lodder J. Thrombolysis for acute stroke with special emphasis on the very old: Experience from a single Dutch center. J Neurol Neurosurg Psychiatry 77 (2006) 375-377
21. Hacke W., Donnan G., Fieschi C., et al. Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363 (2004) 768-774
22. Popa-Wagner A., Badan I., Walker L., et al. Accelerated infarct development, cytogenesis and apoptosis following transient cerebral ischemia in aged rats. Acta Neuropathol (Berl) 113 (2007) 277-293
23. Kharlamov A., Kharlamov E., and Armstrong D.M. Age-dependent increase in infarct volume following photochemically induced cerebral infarction: Putative role of astroglia. J Gerontol A Biol Sci Med Sci 55 (2000) B135-B141
24. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group. Effect of intravenous recombinant tissue plasminogen activator on ischemic stroke lesion size measured by computed tomography. Stroke 31 (2000) 2912-2919
25. Leigh R., Zaidat O.O., Suri M.F., et al. Predictors of hyperacute clinical worsening in ischemic stroke patients receiving thrombolytic therapy. Stroke 35 (2004) 1903-1907
26. Martini S.R., and Kent T.A. Hyperglycemia in acute ischemic stroke: A vascular perspective. J Cereb Blood Flow Metab 27 (2007) 435-451
27. Shaltoni H.M., Albright K.C., Gonzales N.R., et al. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?. Stroke 38 (2007) 80-84
28. The Interventional Management of Stroke Study. Combined intravenous and intra-arterial recanalization for acute ischemic stroke. Stroke 35 (2004) 904-911
29. Zangerle A., Kiechl S., Spiegel M., et al. Recanalization after thrombolysis in stroke patients: Predictors and prognostic implications. Neurology 68 (2007) 39-44
30. Sekoranja L., Loulidi J., Yilmaz H., et al. Intravenous versus combined (intravenous and intra-arterial) thrombolysis in acute ischemic stroke: A transcranial color-coded duplex sonography-guided pilot study. Stroke 37 (2006) 1805-1809
31. Tandberg A.E., Naess H., and Thomassen L. Predictors for recanalization after intravenous thrombolysis in acute ischemic stroke. J Stroke Cerebrovasc Dis 16 (2007) 21-24
32. Engelter S.T., Bonati L.H., and Lyrer P.A. Intravenous thrombolysis in stroke patients of > or = 80 versus < 80 years of age-a systematic review across cohort studies. Age Ageing 35 (2006) 572-580